Shanghai, China, December 25, 2018 – MGI, a subsidiary of BGI and Shanghai Nanodigmbio Biotechnology Co., Ltd. ("Nanodigmbio") have signed a strategic cooperation agreement focusing on high-quality targeted sequencing during the Sequencing Summit China 2018. The two sides will jointly develop library preparation and target capture package based on MGI's sequencing platforms. The signing of this cooperation agreement will promote the use of self-developed equipment, creating a brand-new industri...

"We decided to collaborate with BGI and use all the technology that has been developed by MGI. So far we are very happy with the quality of the data from the project, and it is the best quality we have ever seen." — Dr. Mathias Uhlén Dr. Mathias Uhlén, Professor of Microbiology at Royal Institute of Technology (KTH), founding director of Science for Life Laboratory (SciLifeLab), and senior researcher of Karolinska Institutet, Stockholm, Sweden, gave an inspiring presentation on the topic of...

"Currently, drug-resistant infections affect millions", said Dr. Posch in his speech, "but the diagnostic practice is slow and incomplete, which results in more than 50% of patients being treated inadequately, and 700,000 patients dying of these infections every year." Using the UNYVERO L4 Lysator, all native patient samples (such as sputum, lavage, aspirate, tissue/bone, gastric juice, punctate, drainage, etc.) can be reliably processed, replacing otherwise tedious and time-consuming tradition...

At MGI Technology and Application Conference of Genomics (TACG) held during ICG-13 on October 25, Dr. Yasushi Okazaki, team leader, and Dr. Ken Yagi, deputy team leader of RIKEN Center for Integrative Medical Sciences, gave an inspiring speech about the MGI high-throughput genetic sequencer MGISEQ-2000 as the highly versatile platform to satisfy the multiple needs of RIKEN research projects. RIKEN, as one of the leading national research institutes in Japan, established the Genomic Sciences Cen...

The bio-nanotechnology innovator Xing Technologies (hereinafter “XING”) is a UQ spin-off enterprise specialising in world-leading disease diagnosis and monitoring technologies, including cancer. Its proprietary nano-technologies are transforming the future practice of medicine and healthcare. BGI, a global genomics giant, is the largest organisation in the world in genomics research and applications. With its strong technological capabilities and expertise in gene sequencing and instrument de...